Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic
- 6 April 2020
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 13 (12) , 1484-1488
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic
- Edwards Lifesciences
This publication has 7 references indexed in Scilit:
- Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United StatesCirculation: Cardiovascular Interventions, 2020
- Association Between Wait Time for Transcatheter Aortic Valve Replacement and Early Postprocedural OutcomesJournal of the American Heart Association, 2019
- Temporal Trends and Clinical Consequences of Wait Times for Transcatheter Aortic Valve ReplacementCirculation, 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular CalcificationJACC, 2018
- Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve ReplacementCirculation, 2017
- Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta‐AnalysisJournal of the American Heart Association, 2017
- Complete Revascularization Is Not a Prerequisite for Success in Current Transcatheter Aortic Valve Implantation PracticeJACC: Cardiovascular Interventions, 2013